Noxopharm Limited (ASX:NOX)
Australia · Delayed Price · Currency is AUD 0.0750
-0.0010 (-1.32%)
Apr 17, 2026, 4:10 PM AEST
Noxopharm Market Cap
Noxopharm has a market cap or net worth of 23.04 million as of April 17, 2026. Its market cap has decreased by -12.39% in one year.
Market Cap
23.04M
Enterprise Value
27.20M
Revenue
3.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 23.04M, an increase of 65.70%. That is a compound annual growth rate of 5.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 23.04M | -15.22% |
| Dec 31, 2025 | 27.18M | - |
| Dec 31, 2024 | 27.18M | 30.99% |
| Dec 29, 2023 | 20.75M | -51.03% |
| Dec 30, 2022 | 42.37M | -62.82% |
| Dec 31, 2021 | 113.97M | -9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entropy Neurodynamics | 45.28M |
| Proteomics International Laboratories | 41.30M |
| EZZ Life Science Holdings | 39.07M |
| NeuroScientific Biopharmaceuticals | 34.92M |
| Avecho Biotechnology | 33.06M |
| Argenica Therapeutics | 25.05M |
| Algorae Pharmaceuticals | 24.28M |
| Neurotech International | 17.13M |